TANG CAPITAL PARTNERS LP 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-26 1:00 pm Sale |
2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-28 (Position Closed) |
Filing |
| 2021-11-22 5:28 pm Sale |
2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 28 18.800% |
-26 (-47.65%) |
Filing |
| 2021-06-21 09:00 am Unchanged |
2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 54 39.600% |
0 (Unchanged) |
Filing |
| 2021-02-09 08:30 am Unchanged |
2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 54 40.200% |
0 (Unchanged) |
Filing |
| 2020-11-18 5:03 pm Unchanged |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 54 42.500% |
0 (Unchanged) |
Filing |
| 2020-11-06 4:52 pm Purchase |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 54 54.400% |
54 (New Position) |
Filing |